31 results
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
Summary table of ... used drugs for tuberculosis ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Moxifloxacin #Tuberculosis ... #Medications #management ... #pharmacology # ... Table
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Multidrug-Resistant Tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #dosing #idsa #
Penicillins - Table of Coverage by Generation

Natural PCN  (1st generation): Benzathine PCN, PCN G 

Aminopenicillins
Penicillins - Table ... Generation Natural PCN ... Coverage #Generation #Pharmacology ... #Antibiotics #Table ... #PCN #Management
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
ISCHEMIA Trial - Management ... revascularization (PCI ... evaluation or management ... Angina #ChestPain #Diagnosis ... #Management #Algorithm
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
and Management ... non-toxigenic • Stool PCR ... (IDSA 2021): ... /severe CDI IDSA ... #management #treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Diagnosis: Latent ... staining, NAA (PCR ... #TB #Diagnosis ... #Management #Treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... multidrug-resistant tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #ebm #idsa